GB201012686D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201012686D0
GB201012686D0 GBGB1012686.0A GB201012686A GB201012686D0 GB 201012686 D0 GB201012686 D0 GB 201012686D0 GB 201012686 A GB201012686 A GB 201012686A GB 201012686 D0 GB201012686 D0 GB 201012686D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1012686.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1012686.0A priority Critical patent/GB201012686D0/en
Publication of GB201012686D0 publication Critical patent/GB201012686D0/en
Priority to JP2012533623A priority patent/JP5746703B2/ja
Priority to US13/501,418 priority patent/US8796283B2/en
Priority to PCT/EP2010/065368 priority patent/WO2011045353A1/en
Priority to EP10763718.3A priority patent/EP2488514B1/en
Priority to US14/295,593 priority patent/US20150005321A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1012686.0A 2009-10-16 2010-07-28 Novel compounds Ceased GB201012686D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1012686.0A GB201012686D0 (en) 2010-07-28 2010-07-28 Novel compounds
JP2012533623A JP5746703B2 (ja) 2009-10-16 2010-10-14 α７ｎＡＣｈＲ調節因子としてのインドール及びアザインドール
US13/501,418 US8796283B2 (en) 2009-10-16 2010-10-14 Indole and azaindole modulators of the alpha 7 nachr
PCT/EP2010/065368 WO2011045353A1 (en) 2009-10-16 2010-10-14 Indole and azaindole modulators of the alpha 7 nachr
EP10763718.3A EP2488514B1 (en) 2009-10-16 2010-10-14 Indole and azaindole modulators of the alpha 7 nachr
US14/295,593 US20150005321A1 (en) 2009-10-16 2014-06-04 Indole and azaindole modulators of the alpha 7 nAChR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1012686.0A GB201012686D0 (en) 2010-07-28 2010-07-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB201012686D0 true GB201012686D0 (en) 2010-09-15

Family

ID=42799245

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1012686.0A Ceased GB201012686D0 (en) 2009-10-16 2010-07-28 Novel compounds

Country Status (5)

Country Link
US (2) US8796283B2 (enExample)
EP (1) EP2488514B1 (enExample)
JP (1) JP5746703B2 (enExample)
GB (1) GB201012686D0 (enExample)
WO (1) WO2011045353A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201012686D0 (en) * 2010-07-28 2010-09-15 Glaxo Group Ltd Novel compounds
JP5951600B2 (ja) 2010-05-21 2016-07-13 インフィニティー ファーマシューティカルズ， インコーポレイテッド キナーゼ調節のための、化合物、組成物および方法
US8785470B2 (en) 2011-08-29 2014-07-22 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP2016000697A (ja) * 2012-10-02 2016-01-07 大日本住友製薬株式会社 ピリミジン誘導体
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
CN203873004U (zh) * 2014-05-07 2014-10-15 林光榕 一种双电压电子烟控制组件
CN108059617B (zh) * 2018-02-06 2020-04-07 成都倍特药业股份有限公司 伏立康唑起始物料4-氯-6-乙基-5-氟嘧啶的杂质及其合成方法
CN108997340B (zh) * 2018-09-29 2020-03-20 山东轩德医药科技有限公司 一种5-溴-7-氮杂吲哚的合成方法
CN110372601A (zh) * 2019-06-24 2019-10-25 南京普锐达医药科技有限公司 一种4-氯-6-甲基嘧啶的制备方法
CN111217758A (zh) * 2020-03-18 2020-06-02 湖南复瑞生物医药技术有限责任公司 一种6-乙基-5-氟-4-氯嘧啶的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0530149A1 (de) 1991-08-30 1993-03-03 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
JP4800216B2 (ja) * 2003-10-24 2011-10-26 エグゼリクシス， インコーポレイテッド ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
UY31769A1 (es) * 2008-04-17 2009-09-30 Derivados del indol con actividad modulatoria del receptor nicotínico de acetilcolina
JP5642154B2 (ja) * 2009-04-16 2014-12-17 プロキシマジェン エルティーディーＰｒｏｘｉｍａｇｅｎ Ｌｔｄ． α７ｎＡＣｈＲのインドール誘導体モジュレータ
GB201012686D0 (en) * 2010-07-28 2010-09-15 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
EP2488514B1 (en) 2013-12-25
US20120283273A1 (en) 2012-11-08
WO2011045353A1 (en) 2011-04-21
JP5746703B2 (ja) 2015-07-08
EP2488514A1 (en) 2012-08-22
JP2013507426A (ja) 2013-03-04
US20150005321A1 (en) 2015-01-01
US8796283B2 (en) 2014-08-05

Similar Documents

Publication Publication Date Title
GB201005589D0 (en) Novel compounds
GB201007203D0 (en) Novel compounds
GB201012686D0 (en) Novel compounds
EP2649050A4 (en) LINKS
GB201007791D0 (en) Novel compounds
GB201000685D0 (en) Novel compounds
GB201006126D0 (en) Novel compounds
GB201002094D0 (en) Novel compounds
GB201002096D0 (en) Novel compounds
GB201002097D0 (en) Novel compounds
GB201002112D0 (en) Novel compounds
GB201002797D0 (en) Novel compounds
GB201002799D0 (en) Novel compounds
GB201010508D0 (en) Novel compounds
GB201008985D0 (en) Novel compounds
GB201002818D0 (en) Novel compounds
GB201002821D0 (en) Novel compounds
GB201002827D0 (en) Novel compounds
GB201020909D0 (en) Novel compounds
GB201006124D0 (en) Novel compounds
GB201021310D0 (en) Novel compounds
GB201006128D0 (en) Novel compounds
GB201006846D0 (en) Novel compounds
GB201006847D0 (en) Novel compounds
GB201009341D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)